Artal Group S.A. - FOGHORN THERAPEUTICS INC ownership

FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 40 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of FOGHORN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,604
-29.0%
1,720,7200.0%0.37%
-1.6%
Q2 2023$12,114
+13.6%
1,720,7200.0%0.38%
-40.9%
Q1 2023$10,668
-2.8%
1,720,7200.0%0.63%
+3.4%
Q4 2022$10,978
-99.9%
1,720,7200.0%0.61%
-2.7%
Q3 2022$14,764,000
-36.9%
1,720,7200.0%0.63%
-49.6%
Q2 2022$23,402,000
-10.7%
1,720,7200.0%1.25%
+13.9%
Q1 2022$26,207,000
-33.4%
1,720,7200.0%1.10%
+2.7%
Q4 2021$39,353,000
+64.2%
1,720,7200.0%1.07%
+99.3%
Q3 2021$23,970,000
+30.6%
1,720,7200.0%0.54%
+43.7%
Q2 2021$18,360,000
-19.0%
1,720,7200.0%0.37%
-7.0%
Q1 2021$22,679,000
-35.0%
1,720,7200.0%0.40%
-46.5%
Q4 2020$34,879,0001,720,7200.75%
Other shareholders
FOGHORN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Euclidean Capital LLC 1,261,261$13,458,0004.37%
Birchview Capital, LP 314,143$3,352,0002.00%
Flagship Pioneering Inc. 12,674,120$135,233,0001.73%
Monashee Investment Management LLC 530,581$5,661,0000.68%
Artal Group S.A. 1,720,720$18,360,0000.37%
Alphabet Inc. 500,901$5,345,0000.11%
Casdin Capital, LLC 216,216$2,307,0000.06%
SUVRETTA CAPITAL MANAGEMENT, LLC 84,000$896,0000.01%
NewSquare Capital LLC 5,000$53,0000.01%
FMR LLC 2,540,434$27,106,0000.00%
View complete list of FOGHORN THERAPEUTICS INC shareholders